{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:50Z","timestamp":1790691410613,"version":"4.1.0"},"reference-count":169,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Associazione Italiana per la Ricerca sul Cancro","award":["AIRC IG 23116"],"award-info":[{"award-number":["AIRC IG 23116"]}]},{"name":"Associazione Italiana per la Ricerca sul Cancro","award":["ID 26633"],"award-info":[{"award-number":["ID 26633"]}]},{"name":"AIRC fellowship","award":["AIRC IG 23116"],"award-info":[{"award-number":["AIRC IG 23116"]}]},{"name":"AIRC fellowship","award":["ID 26633"],"award-info":[{"award-number":["ID 26633"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Sphingolipidoses are inborn errors of metabolism due to the pathogenic mutation of genes that encode for lysosomal enzymes, transporters, or enzyme cofactors that participate in the sphingolipid catabolism. They represent a subgroup of lysosomal storage diseases characterized by the gradual lysosomal accumulation of the substrate(s) of the defective proteins. The clinical presentation of patients affected by sphingolipid storage disorders ranges from a mild progression for some juvenile- or adult-onset forms to severe\/fatal infantile forms. Despite significant therapeutic achievements, novel strategies are required at basic, clinical, and translational levels to improve patient outcomes. On these bases, the development of in vivo models is crucial for a better understanding of the pathogenesis of sphingolipidoses and for the development of efficacious therapeutic strategies. The teleost zebrafish (Danio rerio) has emerged as a useful platform to model several human genetic diseases owing to the high grade of genome conservation between human and zebrafish, combined with precise genome editing and the ease of manipulation. In addition, lipidomic studies have allowed the identification in zebrafish of all of the main classes of lipids present in mammals, supporting the possibility to model diseases of the lipidic metabolism in this animal species with the advantage of using mammalian lipid databases for data processing. This review highlights the use of zebrafish as an innovative model system to gain novel insights into the pathogenesis of sphingolipidoses, with possible implications for the identification of more efficacious therapeutic approaches.<\/jats:p>","DOI":"10.3390\/ijms24054747","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T03:29:00Z","timestamp":1677727740000},"page":"4747","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9958-1225","authenticated-orcid":false,"given":"Luca","family":"Mignani","sequence":"first","affiliation":[{"name":"Unit of Experimental Oncology and Immunology and Zebrafish Facility, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Guerra","sequence":"additional","affiliation":[{"name":"Unit of Experimental Oncology and Immunology and Zebrafish Facility, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Corli","sequence":"additional","affiliation":[{"name":"Unit of Experimental Oncology and Immunology and Zebrafish Facility, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1251-8136","authenticated-orcid":false,"given":"Davide","family":"Capoferri","sequence":"additional","affiliation":[{"name":"Unit of Experimental Oncology and Immunology and Zebrafish Facility, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-8376","authenticated-orcid":false,"given":"Marco","family":"Presta","sequence":"additional","affiliation":[{"name":"Unit of Experimental Oncology and Immunology and Zebrafish Facility, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"ref_1","first-page":"363","article-title":"A Treatise on the Chemical Constitution of the Brain: Based Throughout upon Original Researches","volume":"22","author":"Thudichum","year":"1884","journal-title":"Glasgow Med. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"a013326","DOI":"10.1101\/cshperspect.a013326","article-title":"Sphingolipid homeostasis in the endoplasmic reticulum and beyond","volume":"5","author":"Breslow","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tcb.2005.04.006","article-title":"The ins and outs of sphingolipid synthesis","volume":"15","author":"Futerman","year":"2005","journal-title":"Trends Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: From synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrm.2017.16","article-title":"The mystery of membrane organization: Composition, regulation and roles of lipid rafts","volume":"18","author":"Sezgin","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","article-title":"The sphingolipid salvage pathway in ceramide metabolism and signaling","volume":"20","author":"Kitatani","year":"2008","journal-title":"Cell. Signal."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jnc.14540","article-title":"Sphingolipids and neuronal degeneration in lysosomal storage disorders","volume":"148","author":"Grassi","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12944-021-01466-0","article-title":"Sphingolipid lysosomal storage diseases: From bench to bedside","volume":"20","author":"Khodour","year":"2021","journal-title":"Lipids. Health Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12017-010-8133-7","article-title":"Pathology and current treatment of neurodegenerative sphingolipidoses","volume":"12","author":"Eckhardt","year":"2010","journal-title":"Neuromolecular Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Santos, R., and Amaral, O. (2019). Advances in Sphingolipidoses: CRISPR-Cas9 editing as an option for modelling and therapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235897"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fernandez-Pereira, C. (2021). Therapeutic approaches in lysosomal storage diseases. Biomolecules, 11.","DOI":"10.3390\/biom11121775"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ymgme.2022.07.014","article-title":"Therapies for lysosomal storage diseases: Principles, practice, and prospects for refinements based on evolving science","volume":"137","author":"Grabowski","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13023-020-01520-7","article-title":"Identification of risk features for complication in Gaucher\u2019s disease patients: A machine learning analysis of the Spanish registry of Gaucher disease","volume":"15","year":"2020","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.3021","article-title":"The cellular pathology of lysosomal diseases","volume":"226","author":"Cox","year":"2021","journal-title":"J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00109-021-02174-z","article-title":"Gaucher disease-more than just a rare lipid storage disease","volume":"100","author":"Roh","year":"2022","journal-title":"J. Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1038\/s41598-019-42584-1","article-title":"Gene expression profile in patients with Gaucher disease indicates activation of inflammatory processes","volume":"9","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_19","first-page":"2712","article-title":"The contribution of mutant GBA to the development of Parkinson disease in Drosophila","volume":"25","author":"Maor","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Riboldi, G.M., and Di Fonzo, A.B. (2019). Gaucher Disease, and Parkinson\u2019s Disease: From Genetic to Clinic to New Therapeutic Approaches. Cells, 8.","DOI":"10.3390\/cells8040364"},{"key":"ref_21","first-page":"99","article-title":"Are There Neurological Symptoms in Type 1 of Gaucher Disease?","volume":"12","author":"Alaei","year":"2018","journal-title":"Iran. J. Child. Neurol."},{"key":"ref_22","unstructured":"Stone, W.L., Basit, H., and Master, S.R. (2022, November 19). Gaucher disease, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448080\/."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Limgala, R.P., and Goker-Alpan, O. (2020). Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease. Biomolecules, 10.","DOI":"10.3390\/biom10040526"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ajh.26131","article-title":"Upgrading the evidence for the use of ambroxol in Gaucher disease and GBA related Parkinson: Investigator initiated registry based on real life data","volume":"96","author":"Istaiti","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-444-62702-5.00017-2","article-title":"Chapter 17\u2014Fabry disease","volume":"132","author":"Schiffmann","year":"2015","journal-title":"Handb. Clin. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s11255-020-02546-3","article-title":"Fabry disease: Where are we now?","volume":"52","author":"Turkmen","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/cge.14102","article-title":"Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease","volume":"101","author":"Germain","year":"2022","journal-title":"Clin. Genet."},{"key":"ref_28","first-page":"5548445","article-title":"Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging Therapies","volume":"2021","author":"Stamerra","year":"2021","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1025740","DOI":"10.3389\/fphar.2022.1025740","article-title":"Fabry disease: Mechanism and therapeutics strategies","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ivanova, M.M., Changsila, E., Iaonou, C., and Goker-Alpan, O. (2019). Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases. PLoS ONE., 14.","DOI":"10.1371\/journal.pone.0210617"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Song, H.Y. (2021). reversal of the inflammatory responses in Fabry Patient iPSC-Derived cardiovascular endothelial cells by CRISPR\/Cas9-Corrected mutation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052381"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kok, K. (2021). Fabry Disease: Molecular basis, pathophysiology, diagnostics and potential therapeutic directions. Biomolecules, 11.","DOI":"10.3390\/biom11020271"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/jcecho.jcecho_119_20","article-title":"Regional strain pattern and correlation with cardiac magnetic resonance imaging in Fabry Disease","volume":"31","author":"Wang","year":"2021","journal-title":"J. Cardiovasc. Echogr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e007124","DOI":"10.1161\/JAHA.117.007124","article-title":"Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy","volume":"7","author":"Aguiar","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: Evidence for a better outcome with early treatment","volume":"119","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40265-021-01486-1","article-title":"Fabry disease: The current treatment landscape","volume":"81","author":"Lenders","year":"2021","journal-title":"Drugs"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/jimd.12228","article-title":"Developments in the treatment of Fabry disease","volume":"43","author":"Hollak","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3389\/fphys.2017.00982","article-title":"Lysosomal and mitochondrial liaisons in Niemann-Pick disease","volume":"8","author":"Torres","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ymgme.2012.06.015","article-title":"Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: Disease spectrum and natural course in attenuated patients","volume":"107","author":"Hollak","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types A and B Niemann-Pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","article-title":"Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)","volume":"12","author":"McGovern","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejpb.2019.02.019","article-title":"Liposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluation","volume":"137","author":"Aldosari","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41436-021-01156-3","article-title":"One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency","volume":"23","author":"Diaz","year":"2021","journal-title":"Genet. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s11011-021-00842-0","article-title":"Treatment trials in Niemann-Pick type C disease","volume":"36","author":"Sitarska","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00431-017-3020-y","article-title":"Niemann-Pick disease type C in the newborn period: A single-center experience","volume":"176","author":"Gumus","year":"2017","journal-title":"Eur. J. Pediatr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbrc.2007.06.116","article-title":"Defective cholesterol traffic and neuronal differentiation in neural stem cells of Niemann-Pick type C disease improved by valproic acid, a histone deacetylase inhibitor","volume":"360","author":"Kim","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41419-020-03262-7","article-title":"Human iNSC-derived brain organoid model of lysosomal storage disorder in Niemann-Pick disease type C","volume":"11","author":"Lee","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"135841","DOI":"10.1016\/j.neulet.2021.135841","article-title":"Krabbe disease: New hope for an old disease","volume":"752","author":"Bradbury","year":"2021","journal-title":"Neurosci Lett."},{"key":"ref_50","first-page":"3","article-title":"Krabbe disease: A personal perspective and hypothesis","volume":"12","author":"Rafi","year":"2022","journal-title":"Bioimpacts"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/glia.24008","article-title":"Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy","volume":"69","author":"Feltri","year":"2021","journal-title":"Glia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1194\/jlr.M039610","article-title":"Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture","volume":"54","year":"2013","journal-title":"J. Lipid. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1523\/JNEUROSCI.5597-08.2009","article-title":"Psychosine accumulates in membrane microdomains in the brain of Krabbe patients, disrupting the raft architecture","volume":"29","author":"White","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/brain\/awt215","article-title":"Inhibition of angiogenesis by \u03b2-galactosylceramidase deficiency in globoid cell leukodystrophy","volume":"136","author":"Belleri","year":"2013","journal-title":"Brain."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Coltrini, D., Chandran, A.M.K., Belleri, M., Poliani, P.L., Cominelli, M., Pagani, F., Capra, M., Calza, S., Prioni, S., and Mauri, L. (2022). \u03b2-Galactosylceramidase deficiency causes upregulation of long pentraxin-3 in the central nervous system of Krabbe patients and Twitcher Mice. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169436"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13023-018-0766-x","article-title":"Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease","volume":"13","author":"Kwon","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1182\/blood.2020005477","article-title":"Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease","volume":"137","author":"Yoon","year":"2021","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.21037\/atm.2018.04.30","article-title":"Adult-onset Krabbe disease in two generations of a Chinese family","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/humu.24056","article-title":"ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy","volume":"41","author":"Elsea","year":"2020","journal-title":"Hum. Mutat."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/emmm.201302781","article-title":"Farber disease: Understanding a fatal childhood disorder and dissecting ceramide biology","volume":"5","author":"Sands","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1546-0096-5-15","article-title":"Farber disease: Clinical presentation, pathogenesis and a new approach to treatment","volume":"5","author":"Ehlert","year":"2007","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","article-title":"Gangliosides and gangliosidoses: Principles of molecular and metabolic pathogenesis","volume":"33","author":"Sandhoff","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-8552-4_5","article-title":"Ganglioside Metabolism and Its Inherited Diseases","volume":"1804","author":"Breiden","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"734878","DOI":"10.3389\/fgene.2021.734878","article-title":"GM1 Gangliosidosis-A Mini-Review","volume":"12","author":"Nicoli","year":"2021","journal-title":"Front. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ymgme.2017.12.432","article-title":"Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study","volume":"123","author":"Nestrasil","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2017.04.011","article-title":"Infantile gangliosidoses: Mapping a timeline of clinical changes","volume":"121","author":"Kim","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/TACG.S206076","article-title":"GM1 Gangliosidosis: Mechanisms and Management","volume":"14","author":"Rha","year":"2021","journal-title":"Appl. Clin. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13023-018-0844-0","article-title":"Miglustat in Niemann-Pick disease type C patients: A review","volume":"13","author":"Pineda","year":"2018","journal-title":"Orphanet J. Rare. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","article-title":"Substrate reduction therapy of glycosphingolipid storage disorders","volume":"29","author":"Aerts","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e1371","DOI":"10.1002\/mgg3.1371","article-title":"Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience","volume":"8","author":"Fischetto","year":"2020","journal-title":"Mol. Genet. Genomic. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Leal, A.F., Benincore-Fl\u00f3rez, E., Solano-Galarza, D., Garz\u00f3n Jaramillo, R.G., Echeverri-Pe\u00f1a, O.Y., Suarez, D.A., Alm\u00e9ciga-D\u00edaz, C.J., and Espejo-Mojica, A.J. (2020). GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202007.0137.v2"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1007\/s10072-022-06270-x","article-title":"GM2 gangliosidosis AB variant: First case of late onset and review of the literature","volume":"43","author":"Ganne","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1038\/mtm.2015.57","article-title":"Construction of a hybrid \u03b2-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo","volume":"3","author":"Tropak","year":"2016","journal-title":"Mol. Ther. Methods. Clin. Dev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41434-019-0120-5","article-title":"A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases","volume":"27","author":"Ou","year":"2020","journal-title":"Gene Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41591-021-01664-4","article-title":"AAV gene therapy for Tay-Sachs disease","volume":"28","author":"Flotte","year":"2022","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Kot, S., Karumuthil-Melethil, S., Woodley, E., Zaric, V., Thompson, P., Chen, Z., Lykken, E., Keimel, J.G., Kaemmerer, W.F., and Gray, S.J. (2021). Investigating Immune Responses to the scAAV9-. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136751"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3389\/fphys.2018.01663","article-title":"New Approaches to Tay-Sachs Disease Therapy","volume":"9","author":"Solovyeva","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12041-020-01208-8","article-title":"In silico analysis of the effects of disease-associated mutations of \u03b2-hexosaminidase A in Tay-Sachs disease","volume":"99","author":"Kacprzyk","year":"2020","journal-title":"J. Genet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e1550","DOI":"10.1542\/peds.2006-0588","article-title":"The natural history of juvenile or subacute GM2 gangliosidosis: 21 New cases and literature review of 134 previously reported","volume":"118","author":"Maegawa","year":"2006","journal-title":"Pediatrics"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1007\/s10072-021-05757-3","article-title":"Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease","volume":"43","author":"Hennig","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Tim-Aroon, T., Wichajarn, K., Katanyuwong, K., Tanpaiboon, P., Vatanavicharn, N., Sakpichaisakul, K., Kongkrapan, A., Eu-Ahsunthornwattana, J., Thongpradit, S., and Moolsuwan, K. (2021). Infantile onset Sandhoff disease: Clinical manifestation and a novel common mutation in Thai patients. BMC Pediatr., 21.","DOI":"10.1186\/s12887-020-02481-3"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/21678421.2021.1892146","article-title":"Sandhoff disease in the elderly: A case study","volume":"23","year":"2022","journal-title":"Amyotroph. Lateral Scler. Front. Degener"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.25689","article-title":"Natural History of Adult Patients with GM2 Gangliosidosis","volume":"87","author":"Masingue","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.nmd.2021.04.011","article-title":"Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering","volume":"31","author":"Duff","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"576221","DOI":"10.3389\/fmed.2020.576221","article-title":"Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches","volume":"7","author":"Shaimardanova","year":"2020","journal-title":"Front. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"100852","DOI":"10.1016\/j.ymgmr.2022.100852","article-title":"Generation and characterization of motor neuron progenitors and motor neurons using metachromatic leukodystrophy-induced pluripotent stem cells","volume":"31","author":"Hossain","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/bmt.2008.275","article-title":"Metachromatic leukodystrophy: An overview of current and prospective treatments","volume":"42","author":"Biffi","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: Long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/291293a0","article-title":"Production of clones of homozygous diploid zebra fish (Brachydanio rerio)","volume":"291","author":"Streisinger","year":"1981","journal-title":"Nature"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Dudziak, K., Nowak, M., and Sozoniuk, M. (2022). One Host-Multiple Applications: Zebrafish (Danio rerio) as Promising Model for Studying Human Cancers and Pathogenic Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810255"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"940484","DOI":"10.3389\/fnmol.2022.940484","article-title":"Zebrafish as a model organism for neurodegenerative disease","volume":"15","author":"Chia","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/bph.15473","article-title":"Zebrafish as a tractable model of human cardiovascular disease","volume":"179","author":"Bowley","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/7854_2022_343","article-title":"Modelling ADHD-Like Phenotypes in Zebrafish","volume":"57","author":"Fontana","year":"2022","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"104620","DOI":"10.1016\/j.neubiorev.2022.104620","article-title":"Zebrafish as a potential non-traditional model organism in translational bipolar disorder research: Genetic and behavioral insights","volume":"136","author":"Canzian","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_96","unstructured":"Phillips, J.B., and Westerfield, M. (2020). The Zebrafish in Biomedical Research: Biology, Husbandry, Diseases, and Research Applications, American College of Laboratory Animal Medicine."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Crouzier, L., Richard, E.M., Sourbron, J., Lagae, L., Maurice, T., and Delprat, B. (2021). Use of Zebrafish Models to Boost Research in Rare Genetic Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413356"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.celrep.2016.01.016","article-title":"Zebrafish Embryonic Lipidomic Analysis Reveals that the Yolk Cell Is Metabolically Active in Processing Lipid","volume":"14","author":"Fraher","year":"2016","journal-title":"Cell Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1194\/jlr.D072918","article-title":"An HPLC-CAD\/fluorescence lipidomics platform using fluorescent fatty acids as metabolic tracers","volume":"58","author":"Quinlivan","year":"2017","journal-title":"J. Lipid. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fmolb.2020.00082","article-title":"Modeling Lysosomal Storage Diseases in the Zebrafish","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"151739","DOI":"10.1016\/j.scitotenv.2021.151739","article-title":"Using comprehensive lipid profiling to study effects of PFHxS during different stages of early zebrafish development","volume":"808","author":"Xu","year":"2022","journal-title":"Sci. Total. Environ."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"136565","DOI":"10.1016\/j.scitotenv.2020.136565","article-title":"Lipidomics perturbations in the brain of adult zebrafish (Danio rerio) after exposure to chiral ibuprofen","volume":"713","author":"Zhang","year":"2020","journal-title":"Sci. Total. Environ."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Hachicho, N., Reithel, S., Miltner, A., Heipieper, H.J., K\u00fcster, E., and Luckenbach, T. (2015). Body Mass Parameters, Lipid Profiles and Protein Contents of Zebrafish Embryos and Effects of 2,4-Dinitrophenol Exposure. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134755"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1194\/jlr.S120001025","article-title":"Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures","volume":"61","author":"Liebisch","year":"2020","journal-title":"J. Lipid. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1039\/C6MB00168H","article-title":"Lipid dynamics in zebrafish embryonic development observed by DESI-MS imaging and nanoelectrospray-MS","volume":"12","author":"Pirro","year":"2016","journal-title":"Mol. Biosyst."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"14946","DOI":"10.1038\/s41598-017-14949-x","article-title":"3D MALDI Mass Spectrometry Imaging of a Single Cell: Spatial Mapping of Lipids in the Embryonic Development of Zebrafish","volume":"7","author":"Essner","year":"2017","journal-title":"Sci Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1007\/s00216-020-02661-1","article-title":"Evaluation of LC-MS and LCxLC-MS in analysis of zebrafish embryo samples for comprehensive lipid profiling","volume":"412","author":"Xu","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1038\/s41467-020-17196-3","article-title":"Wnt-controlled sphingolipids modulate Anthrax Toxin Receptor palmitoylation to regulate oriented mitosis in zebrafish","volume":"11","author":"Castanon","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/jssc.202200214","article-title":"Lipidomics profiling of zebrafish liver through untargeted liquid chromatography-high resolution mass spectrometry","volume":"45","author":"Iturrospe","year":"2022","journal-title":"J. Sep. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1194\/jlr.M058941","article-title":"Novel function of vitamin E in regulation of zebrafish (Danio rerio) brain lysophospholipids discovered using lipidomics","volume":"56","author":"Choi","year":"2015","journal-title":"J. Lipid. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"19939","DOI":"10.1038\/s41598-019-56466-z","article-title":"Parallel Reaction Monitoring reveals structure-specific ceramide alterations in the zebrafish","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-3-030-21162-2_4","article-title":"A Stroll Down the CerS Lane","volume":"1159","author":"Zelnik","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/dvdy.23913","article-title":"Identification and expression analysis of the zebrafish homologs of the ceramide synthase gene family","volume":"242","author":"Brondolin","year":"2013","journal-title":"Dev. Dyn."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e21992","DOI":"10.7554\/eLife.21992","article-title":"The ceramide synthase 2b gene mediates genomic sensing and regulation of sphingosine levels during zebrafish embryogenesis","volume":"6","author":"Mendelson","year":"2017","journal-title":"eLife"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Tomasello, D.L., Kim, J.L., Khodour, Y., McCammon, J.M., Mitalipova, M., Jaenisch, R., Futerman, A.H., and Sive, H. (2021). FAM57B is a modulator of ceramide synthesis that regulates sphingolipid homeostasis and synaptic composition in the developing brain. bioRxiv.","DOI":"10.1101\/2021.03.02.433619"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","article-title":"Ensembl 2018","volume":"46","author":"Zerbino","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"100199","DOI":"10.1016\/j.jlr.2022.100199","article-title":"Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish","volume":"63","author":"Lelieveld","year":"2022","journal-title":"J. Lipid Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"iyac016","DOI":"10.1093\/genetics\/iyac016","article-title":"Zebrafish information network, the knowledgebase for Danio rerio research","volume":"220","author":"Bradford","year":"2022","journal-title":"Genetics"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bbalip.2013.12.003","article-title":"The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders","volume":"1841","author":"Taniguchi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1083\/jcb.200903152","article-title":"Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ER","volume":"185","author":"Vacaru","year":"2009","journal-title":"J. Cell. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Reviews. Cancer"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Keatinge, M., Gegg, M.E., Watson, L., Mortiboys, H., Li, N., Dunning, M., Ailani, D., Bui, H., van Rens, A., and Lefeber, D.J. (2020). Unexpected opposing biological effect of genetic risk factors for Parkinson\u2019s disease. bioRxiv.","DOI":"10.1101\/702340"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"29971","DOI":"10.1074\/jbc.M805402200","article-title":"Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis","volume":"283","author":"Yabu","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/cdd.2014.128","article-title":"Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling","volume":"22","author":"Yabu","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/blood-2004-09-3679","article-title":"Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate","volume":"106","author":"Yabu","year":"2005","journal-title":"Blood"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"20349","DOI":"10.1074\/jbc.M109.004580","article-title":"A novel mitochondrial sphingomyelinase in zebrafish cells","volume":"284","author":"Yabu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Bravo, G.\u00c1., Cede\u00f1o, R.R., Casadevall, M.P., and Rami\u00f3-Torrent\u00e0, L. (2022). Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives. Cells, 11.","DOI":"10.3390\/cells11132058"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1074\/jbc.M112.427344","article-title":"Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning","volume":"288","author":"Mendelson","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.1074\/jbc.M114.634717","article-title":"Maternal and Zygotic Sphingosine Kinase 2 Are Indispensable for Cardiac Development in Zebrafish","volume":"290","author":"Hisano","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molimm.2018.08.025","article-title":"Biological function of SPNS2: From zebrafish to human","volume":"103","author":"Zhu","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"100851","DOI":"10.1016\/j.ymgmr.2022.100851","article-title":"Reduced \u03b1-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype","volume":"31","author":"Elsaid","year":"2022","journal-title":"Mol Genet. Metab. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/79951","article-title":"Effective targeted gene \u2019knockdown\u2019 in zebrafish","volume":"26","author":"Nasevicius","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nbt.1939","article-title":"Heritable gene targeting in zebrafish using customized TALENs","volume":"29","author":"Huang","year":"2011","journal-title":"Nat Biotechnol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nbt.1934","article-title":"Targeted gene disruption in somatic zebrafish cells using engineered TALENs","volume":"29","author":"Sander","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/cr.2013.45","article-title":"Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos","volume":"23","author":"Chang","year":"2013","journal-title":"Cell Res."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Hwang, W.Y., Fu, Y., Reyon, D., Maeder, M.L., Kaini, P., Sander, J.D., Joung, J.K., Peterson, R.T., and Yeh, J.R. (2013). Heritable and precise zebrafish genome editing using a CRISPR-Cas system. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068708"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Gagnon, J.A., Valen, E., Thyme, S.B., Huang, P., Akhmetova, L., Pauli, A., Montague, T.G., Zimmerman, S., Richter, C., and Schier, A.F. (2014). Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098186"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/hmg\/ddu538","article-title":"Glucocerebrosidase deficiency in zebrafish affects primary bone ossification through increased oxidative stress and reduced Wnt\/\u03b2-catenin signaling","volume":"24","author":"Zancan","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1093\/hmg\/ddv369","article-title":"Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death","volume":"24","author":"Keatinge","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1194\/jlr.RA119000154","article-title":"Role of \u03b2-glucosidase 2 in aberrant glycosphingolipid metabolism: Model of glucocerebrosidase deficiency in zebrafish","volume":"60","author":"Lelieveld","year":"2019","journal-title":"J. Lipid. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1194\/jlr.M012377","article-title":"Requirement of Npc1 and availability of cholesterol for early embryonic cell movements in zebrafish","volume":"52","author":"Schwend","year":"2011","journal-title":"J. Lipid. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"dmm034165","DOI":"10.1242\/dmm.034165","article-title":"Modeling Niemann-Pick disease type C1 in zebrafish: A robust platform for in vivo screening of candidate therapeutic compounds","volume":"11","author":"Tseng","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1515\/hsz-2018-0118","article-title":"Model construction of Niemann-Pick type C disease in zebrafish","volume":"399","author":"Lin","year":"2018","journal-title":"Biol. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"647860","DOI":"10.3389\/fncel.2021.647860","article-title":"npc2-Deficient Zebrafish Reproduce Neurological and Inflammatory Symptoms of Niemann-Pick Type C Disease","volume":"15","author":"Wiweger","year":"2021","journal-title":"Front. Cell. Neuro."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"dev194258","DOI":"10.1242\/dev.194258","article-title":"The role of Niemann-Pick type C2 in zebrafish embryonic development","volume":"148","author":"Tseng","year":"2021","journal-title":"Development"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbadis.2014.01.008","article-title":"Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe\u2019s disease","volume":"1842","author":"Zizioli","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1","volume":"91","author":"Zhou","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cell.2016.02.034","article-title":"Lysosomal Disorders Drive Susceptibility to Tuberculosis by Compromising Macrophage Migration","volume":"165","author":"Berg","year":"2016","journal-title":"Cell"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.chembiol.2009.02.010","article-title":"Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets","volume":"16","author":"Wallgard","year":"2009","journal-title":"Chem. Biol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/glia.23641","article-title":"Hexb enzyme deficiency leads to lysosomal abnormalities in radial glia and microglia in zebrafish brain development","volume":"67","author":"Kuil","year":"2019","journal-title":"Glia"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41467-021-23452-x","article-title":"Cytosolic dsDNA of mitochondrial origin induces cytotoxicity and neurodegeneration in cellular and zebrafish models of Parkinson\u2019s disease","volume":"12","author":"Matsui","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Marques, A.R., Aten, J., Ottenhoff, R., van Roomen, C.P., Herrera Moro, D., Claessen, N., Vinueza Veloz, M.F., Zhou, K., Lin, Z., and Mirzaian, M. (2015). Reducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C Mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135889"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/B978-0-444-52902-2.00037-0","article-title":"Chapter 37\u2014Fabry disease","volume":"115","author":"Toyooka","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Hayashi, T., Okamoto, R., Kawano, T., and Iwasaki, T. (2019). Development of Organelle Replacement Therapy Using a Stearyl-Polyhistidine Peptide against Lysosomal Storage Disease Cells. Molecules, 24.","DOI":"10.3390\/molecules24162995"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ajmg.a.32642","article-title":"The clinical spectrum of fetal Niemann-Pick type C","volume":"149A","author":"Spiegel","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2353\/ajpath.2009.090210","article-title":"Altered chondrocyte differentiation and extracellular matrix homeostasis in a zebrafish model for mucolipidosis II","volume":"175","author":"Sias","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Lu, P.N., Moreland, T., Christian, C.J., Lund, T.C., Steet, R.A., and Flanagan-Steet, H. (2020). Inappropriate cathepsin k secretion promotes its enzymatic activation driving heart and valve malformation. JCI Insight, 5.","DOI":"10.1172\/jci.insight.133019"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1074\/jbc.M114.612507","article-title":"Analysis of mucolipidosis ii\/iii gnptab missense mutations identifies domains of udp-glcnac:Lysosomal enzyme glcnac-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition","volume":"290","author":"Qian","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.matbio.2009.09.001","article-title":"A novel functional role of iduronate-2-sulfatase in zebrafish early development","volume":"29","author":"Moro","year":"2010","journal-title":"Matrix Biol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/hmg\/ddx069","article-title":"Perturbations in cell signaling elicit early cardiac defects in mucopolysaccharidosis type II","volume":"26","author":"Costa","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/hmg\/ddy131","article-title":"Fgf signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (mpsII)","volume":"27","author":"Bellesso","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Lin, C.Y., Lin, H.Y., Chuang, C.K., Zhang, P.H., Tu, R.Y., Lin, S.P., and Tsai, H.J. (2020). Effect of mutated ids overexpression on ids enzyme activity and developmental phenotypes in zebrafish embryos: A valuable index for assessing critical point-mutations associated with mucopolysaccharidosis type II occurrence in humans. Diagnostics, 10.","DOI":"10.3390\/diagnostics10100854"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jnr.22564","article-title":"Persistence of psychosine in brain lipid rafts is a limiting factor in the therapeutic recovery of a mouse model for Krabbe disease","volume":"89","author":"White","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/NEN.0b013e3182724831","article-title":"Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses","volume":"71","author":"MacMillan","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1566523218666180404162622","article-title":"Genetics and Therapies for GM2 Gangliosidosis","volume":"18","author":"Zaccariotto","year":"2018","journal-title":"Curr. Gene Ther."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/bs.mcb.2016.10.004","article-title":"Chemical screening in zebrafish for novel biological and therapeutic discovery","volume":"138","author":"Wiley","year":"2017","journal-title":"Methods Cell. Biol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41573-021-00210-8","article-title":"Zebrafish disease models in drug discovery: From preclinical modelling to clinical trials","volume":"20","author":"Patton","year":"2021","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/5\/4747\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:45:07Z","timestamp":1760121907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/5\/4747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":169,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["ijms24054747"],"URL":"https:\/\/doi.org\/10.3390\/ijms24054747","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}